• Contact

  • Newsletter

  • About us

  • Delivery options

  • Prospero Book Market Podcast

  • Nanotherapeutics for Treating Neurodegenerative Disorders

    Nanotherapeutics for Treating Neurodegenerative Disorders by Chourasia, Manish K.; Saraf, Shubhini A.; Pathak, Yashwant; Chaurasia, Mohini;

      • GET 10% OFF

      • The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
      • Publisher's listprice EUR 139.99
      • The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

        58 060 Ft (55 296 Ft + 5% VAT)
      • Discount 10% (cc. 5 806 Ft off)
      • Discounted price 52 255 Ft (49 766 Ft + 5% VAT)

    58 060 Ft

    db

    Availability

    Not yet published.

    Why don't you give exact delivery time?

    Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.

    Product details:

    • Publisher Elsevier Science
    • Date of Publication 1 May 2026

    • ISBN 9780443336232
    • Binding Paperback
    • No. of pages350 pages
    • Size 229x152 mm
    • Weight 450 g
    • Language English
    • 0

    Categories

    Long description:

    Nanotherapeutics for Treating Neurodegenerative Disorders is a comprehensive guide to the cutting-edge field of nanotherapeutics. This book reviews the complex landscape of neurodegenerative disorders, outlining the nuances of treatment strategies and the imperative role of nanotechnology in revolutionizing therapeutic interventions. From explaining the transport mechanisms of the Blood-Brain Barrier to unveiling the therapeutic potential of stem cell-derived nanocarriers, each chapter offers invaluable insights into the diverse array of nanotherapeutic approaches helping to reshape the landscape of neurological healthcare. By consolidating current updates on advanced targets-based nanotherapeutics, this book provides a comprehensive resource for neurodegenerative diseases converge. Whether seeking to unravel the complexities of mitochondrial dysfunction or harness the potential of nanocarriers for targeted genetic material delivery, readers will find themselves equipped with the tools to navigate the forefront of neurotherapeutic innovation.

    More

    Table of Contents:

    1. Concepts, types, and treatment strategies for neurodegenerative disorders
    2. Transport mechanisms of the Blood-Brain Barrier
    3. Need of nanotherapeutics against neurodegenerative disorders
    4. Nanotechnology mediated drug delivery for addressing protein aggregation
    5. Nanocarriers focusing on synuclein misfolding as a therapeutic target
    6. Therapeutic potential of stem cells derived nanocarriers in neurological disorders
    7. Emphasizing mitochondrial dysfunction and autophagy in the treatment of neurological disorders
    8. Nanocarriers assisted delivery of genetic material for the treatment of neurodegenerative disorders
    9. Nanotherapeutics targeting neuroinflammation
    10. Nanocarriers mediated DNA repair mechanism against neurological disorders
    11. Nanotherapy for targeted inhibition of PERK: Unravelling stress-induced endoplasmic reticulum kinase
    12. Targeting microglial inhibition via nanotechnology: A strategy to halt protein degradation
    13. Nanocarriers unveiling ferroptosis as a potential therapeutic target
    14. Proteostasis maintenance through nanocarriers: Mitigating protein misfolding, mitochondrial impairment, and oxidative stress
    15. Modulation of Hippo signaling pathway dysregulation through nanotechnology for neurodegenerative disorders
    16. Nanocarriers modulating fibrinolytic pathways for the treatment of various neurological disorders
    17. Targeting glial cells through nanotherapeutic strategies in neurological disorders
    18. Oligodendrocytes as an emerging therapeutic target in neurological disorders

    More